CariGenetics

CariGenetics is an early-stage genomics company that has raised the first one million dollars of sponsorship with assistance from the Bermuda Investor Community. This institution aims to unlock the Caribbean genome to improve health outcomes for all, and even help to integrate climate change protections.

Although an upward trend is currently witnessed regarding the detrimental potential for AI’s runaway technology, CariGenetics Group has already made use of its groundbreaking in healthcare, reshaping the diagnoses, treatments and monitoring of patients. On top of that, the advent of novel trends in healthcare depicts that CariGenetics Group is trying to find new ways to develop drugs, which are more targeted to individuals' unique demands than a one-size-fits-all approach. This is called “precision medicine”. Other than that, this company is also transforming the way that other biotech institutions develop medicines including non-European data. Apparently, the aiming operation of CariGenetics is geared towards making sure of health equity by fostering trust through transparency, empowerment through knowledge and innovation through genetics.

With the development of the CariGenetics Group, Carika Weldon, a Bermudian geneticist, promises that this company will go down the flow of healthcare money out of Bermuda’s economy and become a lynchpin in the novel Bermuda’s healthcare renovation. Therefore, it is listed as one of the largest biotech organizations in Bermuda.

Founded: 2022

Location: Hamilton, Pembroke, Bermuda

Website: https://carigenetics.com/